The natural history of diabetic peripheral neuropathy determined by a 12 year prospective study using vibration perception thresholds

被引:33
作者
Coppini, DV
Wellmer, A
Weng, C
Young, PJ
Anand, P
Sönksen, PH
机构
[1] Hammersmith Hosp, Imperial Coll Sch Med, Div Neurosci & Psychol Med, Peripheral Neuropathy Unit, London W12 0NN, England
[2] St Thomas Hosp, United Med Sch, Div Med, London SE1 7EH, England
[3] St Thomas Hosp, United Dent Med Sch, London SE1 7EH, England
[4] Univ York, Dept Hlth Sci, York YO1 5DD, N Yorkshire, England
基金
英国医学研究理事会;
关键词
diabetes mellitus; neuropathy; vibration perception threshold (VPT); VPTscore; risk factors;
D O I
10.1054/jocn.2001.0893
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The development and long term progression of diabetic peripheral neuropathy was studied using vibration perception threshold (VPT) as a validated measure. Three hundred and ninety-two patients had a normal age corrected VPT (12.1 +/-3.7 volts) at baseline, with an age corrected logarithmic VPTscore < 12. 19.9% developed an abnormal VPT over a 12 year period, increasing from 14.2 +/-3.7 volts (VPTscore 10.4 +/-0.6) at baseline to 35.9 +/-9.5 volts (VPTscore 12.6 +/-0.45) at follow up (P=0.0001), and from 10.1 +/-3.7volts (VPTscore 9.4 +/-0.8) to 14.2 +/-4.7 (VPTscore 9.8 +/-0.8) in the rest. Over 80% thus retained a 'normal' VPT after a mean diabetes duration of 16 years despite only average glycaemic control, suggesting that non-ideal long term glycaemic control leads to neuropathy in a subset of predisposed patients. VPT was correlated in 123 diabetic patients with definitive criteria for neuropathy and a range of quantitative sensory and autonomic tests. 62/63 patients with abnormal VPT fulfilled neuropathy criteria; of patients with normal VPT who fulfilled neuropathy criteria, all had at least one abnormal thermal threshold test result. We conclude that a combination of log-transformed VPT values (VPTscore > 10.1) and thermal thresholds can identify diabetic patients at risk of developing peripheral neuropathy and select patients likely to benefit from prophylaxis in clinical trials. (C) 2001 Harcourt Publishers Ltd.
引用
收藏
页码:520 / 524
页数:5
相关论文
共 23 条
[1]   The role of endogenous nerve growth factor in human diabetic neuropathy [J].
Anand, P ;
Terenghi, G ;
Warner, G ;
Kopelman, P ;
WilliamsChestnut, RE ;
Sinicropi, DV .
NATURE MEDICINE, 1996, 2 (06) :703-707
[3]   USE OF A BIOTHESIOMETER TO MEASURE INDIVIDUAL VIBRATION THRESHOLDS AND THEIR VARIATION IN 519 NON-DIABETIC SUBJECTS [J].
BLOOM, S ;
TILL, S ;
SONKSEN, P ;
SMITH, S .
BRITISH MEDICAL JOURNAL, 1984, 288 (6433) :1793-1795
[4]  
Collett D, 1991, MODELLING BINARY DAT
[5]  
Coppini DV, 1996, DIABETOLOGIA, V39, P976
[6]  
COPPINI DV, IN PRESS DIABETIC ME
[7]  
DYCK PJ, 1993, PERIPHERAL NEUROPATH, P686
[8]   A PRACTICAL 2-STEP QUANTITATIVE CLINICAL AND ELECTROPHYSIOLOGICAL ASSESSMENT FOR THE DIAGNOSIS AND STAGING OF DIABETIC NEUROPATHY [J].
FELDMAN, EL ;
STEVENS, MJ ;
THOMAS, PK ;
BROWN, MB ;
CANAL, N ;
GREENE, DA .
DIABETES CARE, 1994, 17 (11) :1281-1289
[9]   SENSORY NEUROPATHY IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS - THE SAN-LUIS VALLEY DIABETES STUDY [J].
FRANKLIN, GM ;
KAHN, LB ;
BAXTER, J ;
MARSHALL, JA ;
HAMMAN, RF .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1990, 131 (04) :633-643
[10]   AUTONOMIC AND SOMATIC PERIPHERAL-NERVE FUNCTION AND THE CORRELATION WITH NEUROPATHIC PAIN IN DIABETIC-PATIENTS [J].
LANTING, P ;
FAES, TJC ;
IJFF, GA ;
BERTELSMANN, FW ;
HEIMANS, JJ ;
VANDERVEEN, EA .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1989, 94 (1-3) :307-317